The popularity of Sildenafil initially sparked a surge for major pharmaceutical companies, but recent shifts present a complicated outlook for those considering a stake. Lower-cost alternatives are eating into profits, https://joycenxfs711697.iyublog.com/39962522/viagra-and-big-pharma-a-volatile-investment